New York State Common Retirement Fund
MRNS

New York State Common Retirement Fund’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

New York State Common Retirement Fund’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-460
Closed -$538 – 3420
2024
Q2 		$538 Sell
460
-16,645
-97% -$41.6K ﹤0.01% 3332
2024
Q1 		$155K Sell
17,105
-15
-0.1% -$146 ﹤0.01% 2553
2023
Q4 		$186K Sell
17,120
-2,926
-15% -$21.9K ﹤0.01% 2488
2023
Q3 		$161K Buy
20,046
+546
+3% +$4.54K ﹤0.01% 2514
2023
Q2 		$212K Buy
+19,500
New +$167K ﹤0.01% 2469
2022
Q3 		– Sell
-260
Closed -$1K – 3501
2022
Q2 		$1K Sell
260
-23,302
-99% -$142K ﹤0.01% 3441
2022
Q1 		$220K Buy
23,562
+3
+0% +$30 ﹤0.01% 2790
2021
Q4 		$280K Sell
23,559
-81
-0.3% -$935 ﹤0.01% 2741
2021
Q3 		$269K Sell
23,640
-8,252
-26% -$113K ﹤0.01% 2778
2021
Q2 		$572K Buy
31,892
+9,643
+43% +$155K ﹤0.01% 2526
2021
Q1 		$344K Buy
22,249
+3,700
+20% +$53.5K ﹤0.01% 2636
2020
Q4 		$226K Hold
18,549
– – ﹤0.01% 2709
2020
Q3 		$238K Sell
18,549
-1
-0% -$9 ﹤0.01% 2566
2020
Q2 		$188K Buy
18,550
+12,000
+183% +$110K ﹤0.01% 2665
2020
Q1 		$53K Hold
6,550
– – ﹤0.01% 2972
2019
Q4 		$57K Hold
6,550
– – ﹤0.01% 3107
2019
Q3 		$40K Sell
6,550
-6,350
-49% -$51.3K ﹤0.01% 3172
2019
Q2 		$214K Buy
12,900
+6,450
+100% +$112K ﹤0.01% 2781
2019
Q1 		$108K Hold
6,450
– – ﹤0.01% 2931
2018
Q4 		$74K Hold
6,450
– – ﹤0.01% 3031
2018
Q3 		$258K Hold
6,450
– – ﹤0.01% 2719
2018
Q2 		$182K Buy
+6,450
New +$143K ﹤0.01% 2912

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

New York State Common Retirement Fund's MRNS Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2024, closing a stake of 460 shares — an estimated $538 sold.

New York State Common Retirement Fund first reported a position in MRNS in Q2 2018 and held it in 22 quarters. The position peaked at $572K in Q2 2021. 75 funds tracked by Wall St. Rank hold MRNS as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 460 Marinus Pharmaceuticals, Inc shares in Q3 2024, an estimated $538.
  • New York State Common Retirement Fund first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and held it in 22 quarters.
  • New York State Common Retirement Fund's Marinus Pharmaceuticals, Inc position peaked at $572K in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.